FIGURE

Fig. 1

ID
ZDB-FIG-180807-25
Publication
Sztal et al., 2018 - Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy
Other Figures
All Figure Page
Back to All Figure Page
Fig. 1

Characterization of the neb (sa906) mutant zebrafish strain. a & b) At 4 dpf neb−/− zebrafish (aii) appear smaller in size and (bii) display a loss of birefringence compared to their wildtype siblings (ai & bi). c) RT-PCR analysis in and neb−/− mutant embryos at 2 dpf shows a reduction in neb mRNA levels compared to wildtype siblings (sibling). βAct was used as a positive control. d) ii) neb−/− mutants display a smaller eye, brain region (B) and deflated swim bladder (SB) compared to their i) wildtype siblings. e) Quantification of the maximum acceleration recorded from touch-evoked response assays of neb−/− fish compared to wildtype siblings at 2 dpf. Error bars represent mean±SEM for three independent experiments (n = 11,9,12 neb −/− , 55,25,32 neb +/− , 18,13,12 neb +/+ zebrafish per experiment), **p < 0.01. f & g) Quantification of the normalized (f) distance and (g) speed travelled by neb−/− mutants compared to wildtype siblings at 6 dpf. For f) error bars represent median±interquartile range for three independent experiments (for n = 19,23,19 neb −/− , 41,42,36 neb +/− , 31,20,21 neb +/+ zebrafish). For g) error bars represent mean±SEM range (for n = 19,23,14 neb −/− , 41,42,36 neb +/− , 30,20,21 neb +/+ zebrafish per experiment). *p < 0.5, **** p < 0.001

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Observed In:
Stage Range: Long-pec to Day 6

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Neuropathol Commun